Literature DB >> 29794144

Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease.

Satheesh Chonat1,2, Maa-Ohui Quarmyne3,2, Caroline M Bennett3,2, Christina L Dean4, Clinton H Joiner3,2, Ross M Fasano2,4, Sean R Stowell4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29794144      PMCID： PMC6165824          DOI： 10.3324/haematol.2018.194670

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   11.047


× No keyword cloud information.
  16 in total

1.  Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.

Authors:  F Pirenne; P Bartolucci; A Habibi
Journal:  Transfus Clin Biol       Date:  2017-06-29       Impact factor: 1.406

2.  Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.

Authors:  Shruti Gupta; Andrew Fenves; Sandra Taddie Nance; David B Sykes; Walter Sunny Dzik
Journal:  Transfusion       Date:  2014-09-26       Impact factor: 3.157

3.  Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.

Authors:  David Narbey; Anoosha Habibi; Philippe Chadebech; Armand Mekontso-Dessap; Mehdi Khellaf; Jean-Daniel Lelièvre; Bertrand Godeau; Marc Michel; Frédéric Galactéros; Rachid Djoudi; Pablo Bartolucci; France Pirenne
Journal:  Am J Hematol       Date:  2017-10-31       Impact factor: 10.047

4.  Heme interacts with c1q and inhibits the classical complement pathway.

Authors:  Lubka T Roumenina; Maria Radanova; Boris P Atanasov; Krastio T Popov; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Véronique Frémeaux-Bacchi; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

5.  Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.

Authors:  Robert S Nickel; John T Horan; Ross M Fasano; Erin Meyer; Cassandra D Josephson; Anne M Winkler; Marianne E M Yee; Leslie S Kean; Jeanne E Hendrickson
Journal:  Am J Hematol       Date:  2015-10-06       Impact factor: 10.047

6.  Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.

Authors:  Marie Frimat; Fanny Tabarin; Jordan D Dimitrov; Caroline Poitou; Lise Halbwachs-Mecarelli; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Blood       Date:  2013-05-21       Impact factor: 22.113

7.  Extracellular hemin crisis triggers acute chest syndrome in sickle mice.

Authors:  Samit Ghosh; Olufolake Adetoro Adisa; Prasanthi Chappa; Fang Tan; Kesmic Ann Jackson; David Robert Archer; Solomon Fiifi Ofori-Acquah
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Liming Milbauer; Fuad Abdulla; Abdu I Alayash; Ann Smith; Karl A Nath; Robert P Hebbel; Gregory M Vercellotti
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

9.  Global gene expression profiling of endothelium exposed to heme reveals an organ-specific induction of cytoprotective enzymes in sickle cell disease.

Authors:  Samit Ghosh; Fang Tan; Tianwei Yu; Yuhua Li; Olufolake Adisa; Mario Mosunjac; Solomon F Ofori-Acquah
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

Review 10.  Initiation and regulation of complement during hemolytic transfusion reactions.

Authors:  Sean R Stowell; Anne M Winkler; Cheryl L Maier; C Maridith Arthur; Nicole H Smith; Kathryn R Girard-Pierce; Richard D Cummings; James C Zimring; Jeanne E Hendrickson
Journal:  Clin Dev Immunol       Date:  2012-10-16
View more
  22 in total

Review 1.  Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells.

Authors:  Melissa M Lee-Sundlov; Sean R Stowell; Karin M Hoffmeister
Journal:  J Thromb Haemost       Date:  2020-05-28       Impact factor: 5.824

Review 2.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

3.  Critical role of C5a in sickle cell disease.

Authors:  Gregory M Vercellotti; Agustin P Dalmasso; Terry R Schaid; Julia Nguyen; Chunsheng Chen; Marna E Ericson; Fuad Abdulla; Trevor Killeen; Margaret A Lindorfer; Ronald P Taylor; John D Belcher
Journal:  Am J Hematol       Date:  2019-01-03       Impact factor: 10.047

Review 4.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

5.  Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease.

Authors:  Aline Floch; Alexandre Morel; Fabian Zanchetta-Balint; Catherine Cordonnier-Jourdin; Slimane Allali; Maximilien Grall; Ghislaine Ithier; Benjamin Carpentier; Sadaf Pakdaman; Jean-Claude Merle; Radjiv Goulabchand; Tackwa Khalifeh; Ana Berceanu; Cécile Helmer; Christelle Chantalat-Auger; Véronique Frémeaux-Bacchi; Marc Michel; Mariane de Montalembert; Armand Mekontso-Dessap; France Pirenne; Anoosha Habibi; Pablo Bartolucci
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

6.  Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.

Authors:  Connie M Arthur; Jerry William L Allen; Hans Verkerke; Justin Yoo; Ryan P Jajosky; Kathryn Girard-Pierce; Satheesh Chonat; Patricia Zerra; Cheryl Maier; Jen Rha; Ross Fasano; Cassandra D Josephson; John D Roback; Sean R Stowell
Journal:  Blood Adv       Date:  2021-01-26

7.  Antibody-mediated immune suppression by antigen modulation is antigen-specific.

Authors:  Cheryl L Maier; Amanda Mener; Seema R Patel; Ryan P Jajosky; Ashley L Bennett; Connie M Arthur; Jeanne E Hendrickson; Sean R Stowell
Journal:  Blood Adv       Date:  2018-11-13

8.  Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses.

Authors:  Amanda Mener; Seema R Patel; Connie M Arthur; Satheesh Chonat; Andreas Wieland; Manjula Santhanakrishnan; Jingchun Liu; Cheryl L Maier; Ryan P Jajosky; Kathryn Girard-Pierce; Ashley Bennett; Patricia E Zerra; Nicole H Smith; Jeanne E Hendrickson; Sean R Stowell
Journal:  JCI Insight       Date:  2018-11-15

Review 9.  Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.

Authors:  Connie M Arthur; Satheesh Chonat; Ross Fasano; Marianne E M Yee; Cassandra D Josephson; John D Roback; Sean R Stowell
Journal:  Transfus Med Rev       Date:  2019-10-18

Review 10.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.